Skip to main content
Premium Trial:

Request an Annual Quote

Novartis, Broad Institute to Study Genetics of Diabetes; Data Will Be Made Public

NEW YORK, Oct. 28 (GenomeWeb News) - Novartis' Institutes for BioMedical Research and the Broad Institute have partnered to look for genetic causes of type 2 diabetes, the groups said today.

 

The collaboration, called the Broad-Novartis Diabetes Initiative, will bring together physicians, geneticists, computational scientists, pharmaceutical researchers, and others to identify genetic risk factors for developing the disease and its complications.

 

Researchers will study thousands of DNA samples provided by Leif Groop, a professor of endocrinology at LundUniversity, a scientist known for his work on type 2 diabetes. Groop leads a team that "delineated the phenotypic and genotypic heterogeneity of diabetes and maintains one of the world's largest and most detailed databases of information on diabetic patients," according to a statement released by Novartis and the Broad.

 

Lundwill help Novartis and Broad researchers design and analyze the research program. Their findings will be made freely available to scientists worldwide via the Internet, the partners said.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.